ENDRA Life Sciences Inc. (NDRA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-310.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | $6.2K | $351.6K | — |
| Cost of Revenue | — | — | — | — | — | $0 | $0 | $0 | $172.8K | — |
| Gross Profit | — | — | — | — | — | $0 | $0 | $6.2K | $178.8K | $279.7K |
| Operating Income | -$5.76M | -$10.82M | -$10.52M | -$13.16M | -$11.50M | -$11.50M | -$10.84M | -$9.02M | -$4.63M | -$1.79M |
| Net Income | -$7.03M | -$11.51M | -$10.06M | -$13.18M | -$11.23M | -$11.73M | -$13.31M | -$9.80M | -$5.38M | -$2.78M |
| EPS (Diluted) | $-8.93 | $-56.94 | — | $-4.56 | $-5.55 | $-0.63 | — | — | — | — |
| Total Assets | $3.85M | $4.45M | $6.75M | $9.27M | $12.87M | $8.76M | $7.18M | $7.22M | $6.12M | $490.8K |
| Total Liabilities | $1.59M | $1.89M | $1.10M | $2.07M | $2.09M | $1.60M | $2.42M | $974.6K | $848.2K | $1.38M |
| Shareholders' Equity | $2.26M | $2.56M | $5.66M | $7.20M | $10.78M | $7.17M | $4.76M | $6.25M | $5.28M | -$893.8K |
| Operating Cash Flow | -$5.18M | -$7.40M | -$9.55M | -$12.77M | -$11.12M | -$10.75M | -$8.59M | -$7.70M | -$3.30M | -$1.32M |
| Capital Expenditures | $17.3K | $16.0K | $33.9K | $202.6K | $45.0K | $75.3K | $43.6K | $100.0K | $7.9K | — |
| Shares Outstanding | 1.18M | 536.9K | 5.9K | 3.17M | 2.13M | 34.05M | 8.42M | 7.42M | 3.92M | 723.3K |